1 unchanged sentence
Certain legal proceedings in which we are involved are discussed in Note 16A .
+Added: 2023 Form 10-K
INFORMATION ABOUT OUR EXECUTIVE OFFICERS
9 unchanged sentences
Our Director since February 2018.
+Added: Chris Boshoff 60 Chief Oncology Officer, Executive Vice President since December 2023.
+Added: Chief Oncology Research and Development Officer and Executive Vice President from July 2023 until December 2023.
+Added: Senior Vice President, Oncology, from 2017 until 2023.
Denton 58 Chief Financial Officer, Executive Vice President since May 2022.
2 unchanged sentences
Director of Tapestry, Inc.
−Removed: Effective March 1, 2023, Director of Haleon plc.
−Removed: 2022 Form 10-K 23
−Removed: Name Age Position
−Removed: Mikael Dolsten 64 Chief Scientific Officer and President, Worldwide Research, Development and Medical since January 2019.
+Added: from 2014 to 2023.
+Added: Director of Haleon plc.
+Added: Alexandre de Germay 56 Chief International Commercial Officer, Executive Vice President since December 2023.
+Added: Chief Executive Officer, Laboratoires Majorelle (a specialty pharma company based in France dedicated to women’s health and urology) from 2021 until January 2024 (assisting with transition matters after December 15, 2023).
+Added: From 2020 until 2021 was Senior Vice President;
+Added: Global Franchise Head of Cardiology, Transplant and Established Products, and from 2016 until 2020 was Head of Mature Markets General Medicines of Sanofi.
+Added: Regional President of Asia-Pacific of Pfizer Inc.
+Added: from 2013 until 2016.
+Added: Mikael Dolsten 65 Chief Scientific Officer, President, Pfizer Research and Development since July 2023.
+Added: Chief Scientific Officer and President, Worldwide Research, Development and Medical from January 2019 until July 2023.
President of Worldwide Research and Development from December 2010 until December 2018.
4 unchanged sentences
Director of Agilent Technologies, Inc, and Vimian Group AB.
−Removed: Director of Karyopharm Therapeutics Inc.
−Removed: from 2015 to 2021.
Lidia Fonseca 55 Chief Digital and Technology Officer, Executive Vice President since January 2019.
2 unchanged sentences
Director of Tegna, Inc.
−Removed: and Medtronic plc.
−Removed: Angela Hwang 57 Chief Commercial Officer since October 2022 and President, Global Biopharmaceuticals Group since January 2019.
−Removed: Group President, Pfizer Essential Health from January 2018 until December 2018.
−Removed: Global President, Pfizer Inflammation and Immunology from January 2016 until December 2017.
−Removed: Regional Head, U.S.
−Removed: Vaccines from January 2014 until December 2015.
−Removed: Vice President, Emerging Markets for Primary Care from September 2011 until December 2013.
−Removed: Director of United Parcel Service, Inc.
+Added: from 2014 to 2023.
+Added: Director of Medtronic plc.
Johnson 62 Chief Compliance, Quality and Risk Officer, Executive Vice President since January 2019.
4 unchanged sentences
Executive Vice President, Chief Compliance and Risk Officer from February 2011 until December 2013.
−Removed: Executive Vice President, Chief Compliance Officer from December 2010 until February 2011.
−Removed: Aamir Malik 47 Chief Business Innovation Officer, Executive Vice President since August 2021.
+Added: Aamir Malik 48 Chief U.S.
+Added: Commercial Officer, Executive Vice President since December 2023.
+Added: Chief Business Innovation Officer, Executive Vice President from August 2021 until December 2023.
geographic leadership roles with McKinsey & Company from 2019 to 2021;
4 unchanged sentences
Vice President of the Biotechnology Unit from 2012 until 2014.
−Removed: William Pao 56 Chief Development Officer, Executive Vice President since March 2022.
−Removed: Head of Roche Pharma Research & Early Development (pRED) and member of Roche’s Enlarged Corporate Executive Committee from 2018 until March 2022;
−Removed: Senior Vice President, Global Head Oncology Discovery and Translational Area at Roche pRED from 2014 until 2018.
−Removed: Vanderbilt University Medical Center Adjunct Professor from 2014 to present.
Payal Sahni 49 Chief People Experience Officer, Executive Vice President since January 2022.
6 unchanged sentences
Senior Vice President, Policy, External Affairs and Communications from December 2009 until December 2010.
−Removed: Director of WPP plc from 2013 to 2022.
+Added: 2023 Form 10-K
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.